Investment Strategies News 13 December 2025

Yangzijiang Shipbuilding Stock (SGX: BS6) Weekly Outlook: News, Price Action, Analyst Targets and What to Watch Next Week (Updated 14 Dec 2025)

Updated: 14 December 2025 (Sunday). Yangzijiang Shipbuilding (Holdings) Ltd shares (SGX: BS6 / BS6.SI) last closed at S$3.49 on Friday, 12 Dec 2025, leaving the stock just ~2.5% below its 52‑week high of S$3.58 set in late October. FT Markets+1

14 December 2025

Suncorp Group Limited (ASX: SUN) Stock Outlook: Storm-Claims Update, Reinsurance Impact, Buyback Support and Analyst Targets for the Week Ahead (Updated 14 Dec 2025)

Suncorp Group Limited (ASX: SUN) heads into the week ahead with investors focused on late‑November storm claims, reinsurance retention, and broker targets. Here’s the latest news roundup, what moved the SUN share price this week, and the key catalysts to

14 December 2025

ASX Updates · Insurance Sector · Investment Strategies · Market Outlook · Stock Analysis

Aristocrat Leisure (ASX:ALL) Stock Update: Fitch Upgrade, Buy‑Back Momentum, and the Week Ahead (Updated 14 Dec 2025)

Updated: Sunday, 14 December 2025 (markets closed). Last close:A$56.71 on Friday, 12 December 2025. Aristocrat Aristocrat Leisure Limited (ASX:ALL) heads into the new week with investors balancing three forces that can pull the share price in opposite directions: (1) a

14 December 2025

ASX Updates · Company News · Financial Analysis · Investment Strategies · Stock Market

Orica Limited (ASX: ORI) Stock Update: Buyback Pace, AGM Catalyst, Dividend Date, Analyst Targets and the Week-Ahead Outlook (Updated 14 Dec 2025)

Orica Limited (ASX: ORI) heads into the week of 15–19 December with an AGM catalyst, ongoing on‑market buyback activity, a late‑December dividend payment, and broadly positive analyst targets. Here’s what changed this week—and what could move ORI next. Orica Limited

14 December 2025

AGM Highlights · Dividend Updates · Investment Strategies · Market Outlook · Stock Analysis

AbbVie Stock Outlook (ABBV): Weekly Recap, Fresh Analyst Upgrades, and the Week-Ahead Setup (Updated Dec. 12, 2025)

AbbVie Inc. (NYSE: ABBV) ended the week of Dec. 8–12, 2025 near $223, after a choppy stretch that featured two notable Wall Street moves—an HSBC upgrade and a Morgan Stanley price-target hike—alongside ongoing headlines tied to AbbVie’s oncology and neuroscience

14 December 2025

Analyst Ratings · Investment Strategies · NYSE:ABBV · Pharma Industry · Stock Market · Weekly Recap

Medical Properties Trust (MPW) Stock: This Week’s Slide, Tenant Headlines, Dividend Update, and What to Watch Next Week (Updated Dec. 12, 2025)

Medical Properties Trust (NYSE: MPW) ended the week near $5.10 after a sharp Thursday drop. Here’s what moved MPW stock this week, the latest tenant and legal headlines, analyst forecasts, and the key catalysts to watch in the week ahead.

14 December 2025

Dividend Updates · Investment Strategies · Market News · NYSE:MPW · REITs · Stock Analysis

Realty Income (NYSE: O) Stock This Week: Dividend Hike, $800M Las Vegas Deal, and the Week-Ahead Setup (Updated Dec. 12, 2025)

Realty Income Corporation (NYSE: O) closed this week with investors balancing two fresh, shareholder-friendly headlines—a new dividend increase and a headline-grabbing $800 million preferred equity investment in CityCenter Las Vegas—against the bigger force that still tends to steer net-lease REITs:

14 December 2025

Dividend Investing · Investment Strategies · Market News · Real Estate · Stock Analysis

Nike Stock (NKE) This Week: Fed Rate Cut Fuels a Bounce as Earnings Loom — Latest News, Forecasts and Week-Ahead Setup (Updated Dec. 12, 2025)

Updated: December 12, 2025 (U.S. market close) Nike, Inc. (NYSE: NKE) heads into next week with its biggest near-term catalyst on the calendar: fiscal Q2 2026 earnings on Thursday, Dec. 18 (after the close). Nike Investor Relations After a volatile

13 December 2025

Earnings Reports · Financial Forecasts · Investment Strategies · Nike News · NYSE:NKE · Stock Market

Chubb (CB) Stock Climbs to a New 52-Week High as AIG Deal Chatter Sparks Volatility — Weekly Recap, Forecasts, and the Week Ahead (Updated Dec. 12, 2025)

Chubb Limited (NYSE: CB) closed Friday at $308.47, notching a fresh 52-week high and extending a late-week rally that has been fueled by M&A speculation involving AIG, a steady drumbeat of bullish analyst notes, and a renewed focus on Chubb’s

13 December 2025

Financial News · Investment Strategies · Market Forecasts · NYSE:CB · Stock Market · Weekly Recap

Prologis Stock (PLD) Outlook: Fed Rate Cut, Dividend, Debt Redemption and Analyst Forecasts for the Week Ahead (Updated Dec. 12, 2025)

Prologis, Inc. (NYSE: PLD) closed Friday, Dec. 12 at $130.18 (down 0.29% on the day), after trading between $129.81 and $131.70. After-hours trading showed $131.21 in delayed data. MarketWatch+1 Heading into next week, PLD investors are weighing three major forces

13 December 2025

Dividend Stocks · Investment Strategies · Market Forecasts · NYSE:PLD · Real Estate Investment Trusts · Stock Analysis

Stryker (SYK) Stock This Week: Dividend Hike, New COO, FDA Recall Watchlist — Outlook for the Week Ahead (Updated Dec. 12, 2025)

Stryker Corporation (NYSE: SYK) closed Friday, December 12, 2025, at $354.09, finishing the session up 0.32% and stabilizing after a choppy stretch that began with a sharp selloff early in the week. Investing.com+1 Stryker is a global medical technology company

13 December 2025

Company News · Dividends · Healthcare Stocks · Investment Strategies · NYSE:SYK · Stock Market

Danaher Stock DHR: What Happened This Week, Latest News, and the Week-Ahead Outlook

Updated: December 12, 2025 (U.S. market close) Danaher Corporation stock (NYSE: DHR) finished the week with a sharp Friday pullback after a strong midweek rebound—leaving investors with the same big question heading into next week: was this just normal volatility

13 December 2025

Company News · Danaher · Investment Strategies · NYSE:DHR · Stock Market · Weekly Outlook

Investment Strategies News 13 December 2025 - 14 December 2025